Boehringer’s Cyltezo, The Only Interchangeable Humira Biosimilar, Gets A New Form

Subcutaneous Form Has Been FDA-Approved Since 2017; Interchangeable Since 2021

 
• By Dean Rudge
  
boehringer hq
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products